| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Baroda BNP Paribas Health and Wellness Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.58 |
| Equity |
98.03 |
| Trep |
2.55 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
31.68% |
| Top 10 Holdings |
54.66% |
| Top 25 Holdings |
92.63% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
72.66 |
| Healthcare |
17.24 |
| Miscellaneous |
5.44 |
| Cash |
1.97 |
| Software & Services |
1.52 |
| Retail |
1.17 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
7.15 |
| PE Ratio |
46.84 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
7.58 |
| Lupin Limited |
6.56 |
| Laurus Labs Limited |
6.31 |
| IPCA Laboratories Limited |
5.80 |
| Torrent Pharmaceuticals Limited |
5.43 |
| DIVI LABORATORIES LTD |
5.35 |
| Apollo Hos Ent Ltd |
4.87 |
| J B Chemicals and Pharma Ltd |
4.57 |
| Fortis Health Care Ltd |
4.32 |
| ASTRAZENCA PHARMA INDIA LTD. |
3.87 |
| Emcure Pharmaceuticals Limited |
3.60 |
| SBI Life Insurance Co Ltd |
3.19 |
| Glenmark Pharmaceuticals Limited |
3.19 |
| Mankind Pharma Limited |
2.99 |
| Aurobindo Pharma Limited |
2.85 |
| Clearing Corporation of India Ltd |
2.55 |
| Dr Lal Path Labs Ltd |
2.53 |
| Zydus Lifesciences Limited |
2.51 |
| Aster DM Healthcare Limited |
2.41 |
| ACUTAAS CHEMICALS LIMITED |
2.30 |
| Max Financial Services Limited |
2.25 |
| Abbott India Limited |
2.07 |
| Ajanta Pharma Limited |
1.95 |
| Nephrocare Health Service Pvt. Ltd. |
1.84 |
| Concord Biotech Limited |
1.74 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|